
OHSU Knight Cancer Institute tapped for participation in a national consortium to accelerate cancer drug discovery
December 20, 2022
As the only center in the Pacific Northwest, OHSU will collaborate with other selected centers to address unmet needs in cancer therapy.

A better roadmap for beating a deadly leukemia
August 09, 2022
Using massive data set, OHSU researchers zero in on potential drug target to stop acute myeloid leukemia.

OHSU, Ionis Pharmaceuticals to develop drugs for ‘undruggable’ cancer targets
January 27, 2020
Collaboration aims to expedite discoveries for patients with leukemia.

Three OHSU scientists earn $2.25 million to accelerate innovation, collaboration
January 23, 2020
Inaugural Faculty Excellence Awards will fund research in marijuana use in pregnancy, new therapies for heart disease, leukemia.

OHSU-led effort results in largest cancer dataset of its kind
October 17, 2018
A study involving hundreds of patient samples may reveal new treatment options for patients facing an aggressive form of leukemia.

NIH selects OHSU Knight Cancer Institute to co-lead largest national database for pediatric cancer, rare disease research
August 15, 2017
OHSU will collaborate with other other teams to establish a pediatric cancer and rare disease data program--a first for the pediatric research community.

OHSU Knight Cancer Institute and Pacific Northwest National Laboratory team up to focus on a complex form of leukemia
June 27, 2017
The Office of Cancer Clinical Proteomics Research (OCCPR) at the National Cancer Institute (NCI) announced the institutes that will comprise the Proteogenomic Translational Research Centers, a group created to collaborate with NCI-sponsored clinical trials.
New leads in the struggle against a formidable leukemia
December 04, 2015
A coordinated push to decrypt a complex form of leukemia is delivering a trove of new drug candidates and treatment ideas, a dozen of which will be presented at the American Society of Hematology Annual Meeting in Orlando, Florida (Dec. 5-8).